MLTI-06. Surgical resection plus stereotactic radiosurgery versus SRS alone for large brain metastases: a comparative study

Enrique Gutierrez,Aristotelis Kalyvas,Conrad J. Villafuerte,Barbara-Ann Millar,Tatiana Conrad,Normand Laperriere,Mark Bernstein,Jessica Weiss,Gelareh Zadeh,Paul Kongkham,David B. Shultz

MLTI-06. Surgical resection plus stereotactic radiosurgery versus SRS alone for large brain metastases: a comparative study

2021

Enrique Gutierrez
Aristotelis Kalyvas
Conrad J. Villafuerte
Barbara-Ann Millar
Tatiana Conrad
Normand Laperriere
Mark Bernstein
Jessica Weiss
Gelareh Zadeh
Paul Kongkham
David B. Shultz

Purpose Large brain metastases (BRM) are challenging to manage. Therapeutic options include Stereotactic Radiosurgery (SRS) or surgery (S) with adjuvant SRS. We sought to compare overall survival (OS), radionecrosis (RN), local failure (LF), pachymeningeal (PMD) and leptomeningeal (LMD) disease in patients treated with SRS vs. S+SRS.

Keywords:

Pharmaceutical Adjuvants
overall survival
surgical resection
Adjuvant
Radiosurgery
Medicine
in patient
Radiation necrosis
Radiology
local failure

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations